CHRO - Chromocell Therapeutics Corp Qarzning balans kapitallashuviga nisbati

Chromocell Therapeutics Corp (CHRO) kompaniyasining korporativ logotipi

Chromocell Therapeutics surunkali og'riqlarni davolash uchun opioidga muqobil vosita yaratish orqali ixtisoslashtirilgan klinikalarni nishonga oladi. Biznes shiddatli ilmiy poyga sharoitida o'z formulalarining patent tozaligiga tayanadi. Qarz mablag'larini balansdagi kapitalga nisbatan monitoring qilish emitentning ishonchliligini baholashga yordam beradi, bunda 0.00 qiymati ushbu holatni aks ettiradi, tadqiqotchilardan iborat sodiq shtat esa klinik bosqichlarning muvaffaqiyatini ta'minlaydi.

Chromocell (CHRO) - Balans qiymatiga qarzlar 21.02.2024dan 02.07.2025gacha

Chromocell Therapeutics Corp (CHRO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Chromocell Therapeutics|CHRO - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Chromocell|CHRO - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Chromocell Therapeutics|CHRO - Kompaniyaning xususiy kapitali|Bozor kapitallashuvining balans qiymatiga nisbati chromocell.com|CHRO - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics Corporation|CHRO - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Chromocell
Kompaniyaning jamlanma tahliliyoti:Chromocell Therapeutics - CHRO
Chromocell Therapeutics Corporation asosiy tovari

Ushbu ko'rsatkich Chromocell Therapeutics (CHRO) kompaniyasining fundamental barqarorligini bozor tebranishlaridan ajratadi. Mazkur metrika umumiy majburiyatlarni kapitalning balans qiymati bilan solishtirib, biznesning kreditorlarga qanchalik bog'liqligini aniqlaydi. Firma balans kapitalizatsiyasidagi qarz ulushini tahlil qilish defolt xavfini baholash imkonini beradi. Analgetiklar sektorida yetakchilik uchun shiddatli raqobat mavjud bo'lgan muhitda bunday moliyaviy quvvat hal qiluvchi ahamiyatga ega. Barqaror ko'rsatkich xavfsiz va innovatsion dori vositalarini ishlab chiqish uchun zarur bo'lgan resurslarni kafolatlaydi.

Chromocell Therapeutics kimlar bilan raqobatlashadi

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar VKTX|Qarzning balans qiymatiga nisbati supernus.com|Catalyst Pharmaceuticals, Inc. (CPRX) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati DNLI (Denali)|Qarzning balans kapitallashuviga nisbati Harmony Pharma|Biohaven Corp - Qarzning sof aktivlarga nisbati|AMLX (Amylyx Pharmaceuticals) - Qarzning balans kapitallashuviga nisbati|TRVI: Balans qiymatiga qarzlar|PRAX (Praxis Precision Medicines, Inc.) - Qarzning balans kapitallashuviga nisbati|AVXL (Anavex) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati CBLL (CeriBell Corp)|Balans qiymatiga qarzlar prothena.com|Balans kapitallashuviga qarzlar ALEC (Alector, Inc.)|Qarzning balans qiymatiga nisbati annexonbio.com (ANNX)|OMER: Balans kapitallashuviga qarzlar|Neurogene Inc - Balans qiymatiga qarzlar|ACIU - Qarzning balans kapitallashuviga nisbati|VYGR: Qarzning balans kapitallashuviga nisbati|Neumora Therapeutics (NMRA) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati scilexholding.com|TVGN - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Alpha Cognition Corp (ACOG)|Qarzning balans qiymatiga nisbati Cognition Therapeutics|Qarzning balans kapitaliga nisbati Inhibikase Pharma (IKT)|Balans kapitallashuviga qarzlar Cassava Sciences, Inc.|Qarzning sof aktivlarga nisbati Assertio Holdings ASRT|COYA (Coya) - Balans kapitallashuviga qarzlar|VTGN: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati ovidrx.com OVID|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning sof aktivlarga nisbati|CRVO (CervoMed Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ATHE|CLNN - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati pepgen.com (PEPG)|JUNS: Balans kapitallashuviga qarzlar|RLMD - Balans qiymatiga qarzlar|Annovis Bio, Inc. - Qarzning balans qiymatiga nisbati|Grace Therapeutics, Inc. (GRCE) - Balans kapitallashuviga qarzlar|AIFF - Qarzning balans qiymatiga nisbati|Klotho Neurosciences (KLTO) - Qarzning balans kapitaliga nisbati|NRSN: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Reviva Pharmaceuticals, Inc.|Balans kapitallashuviga qarzlar MTVA (MetaVia Inc)|Qarzning balans qiymatiga nisbati NRXS (neuraxis.com)|Qarzning balans kapitallashuviga nisbati HSDT|Sof aktivlarga qarzlar Passage Bio Inc. PASG|NEUP: Balans kapitallashuviga qarzlar|NERV - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Athira Pharma, Inc. ATHA|ADXN (addextherapeutics.com) - Qarzning sof aktivlarga nisbati|ALZN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CYCN|Protagenic Therapeutics - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar KTTA (pasitheaclinics.com)|CRGT - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati avenuetx.com ATXI|BCLI (BrainStorm Cell Therapeutics) - Balans kapitallashuviga qarzlar|Cara Therapeutics Inc. (CARA) - Balans qiymatiga qarzlar|ELYM: Qarzning balans qiymatiga nisbati|ITCI (Intra-Cellular Therapies, Inc.) - Balans kapitallashuviga qarzlar|LBPH - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati MRNS|NKGen Biotech - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar NeuroBo Pharmaceuticals Inc (NRBO)|Sage Therapeutics, Inc - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Synaptogenix, Inc SNPX|Balans kapitallashuviga qarzlar Trevena, Inc. (TRVN)|VIGL: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Anew Medical WENA|CERE (Cerevel Therapeutics Inc) - Qarzning sof aktivlarga nisbati